Bright Minds Biosciences' CEO, Ian McDonald, shares update on the company's multiple clinical trials.
Similar Posts
Ask A Psychedelic Guide
We welcome back Nick Levich for our “Ask a Psychedelic Professional” series and as part of our “Ask a Psychedelic Guide” episode.
Interview with Joe Moore, Founder & CEO of Psychedelics Today
In this episode, Joe discusses the current landscape of the industry, his thoughts on its general direction, and why we need to defund the DEA to really progress the movement overall.
Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
In this conversation, David and James discuss the great deal of work that Mindset has done to set the stage for the launch of one or more drug candidates into first in-human clinical trials in 2023.
CODY SHANDRAW: The MOST Important Factor Before Investing In Psychedelic Companies
In this interview, David Flores sits down with Cody Shandraw,…
Interview With Dustin Robinson
Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.